InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,889.48
(
0.96%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12467
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Monday, 12/08/2014 10:41:03 AM

Monday, December 08, 2014 10:41:03 AM

Post# of 80490
You have to realize that Ariad is yesterday's news. There is zero sponsorship, no coverage. So many other exciting biotechs. TGTX is one, and it reminds me of Ariad in its glamor years. I think once the dust settles for ASH in a few days, one or two firms will pen some notes on Ariad. I think this reaction from the market on Ariad's delivery of the ASH data also bodes very badly for the molecule NEW news when it is released. And, lets not forget the rotten Q4 sales number of $10 million to $14 million, we have to get through that.





Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up